Highlights
PolyNovo (PNV) operates in the healthcare sector with a focus on regenerative medical devices
Listed on the S&P/ASX 300 and All Ordinaries indexes
Expanding footprint in domestic and international wound care markets
PolyNovo Limited (ASX:PNV) is a medical technology company within the Australian healthcare sector, known for its development of synthetic dermal regeneration products. The company is listed on both the S&P/ASX 300 and the All Ordinaries, reflecting its presence among established Australian-listed firms in the sector.
Product Focus and Core Technology
PolyNovo (ASX:PNV) designs and manufactures NovoSorb, a synthetic polymer technology platform used in wound care and reconstructive surgery. Its primary commercial product, NovoSorb BTM (Biodegradable Temporising Matrix), supports tissue repair following trauma, burns, or surgical procedures. The platform is designed to be absorbed by the body over time, supporting the healing process in complex cases.
Manufacturing and Operational Footprint
The company operates a manufacturing facility located in Melbourne. This site manages the production of its medical-grade polymer products under controlled conditions for domestic and export markets. PolyNovo (ASX:PNV) maintains regulatory approvals for distribution in regions including Australia, the United States, and parts of Europe.
Commercial Expansion and Distribution
PolyNovo (ASX:PNV) continues to broaden its market reach through hospital supply agreements, surgical partnerships, and clinical adoption initiatives. The company’s products are distributed across a range of medical institutions, supported by sales teams in various territories. Distribution channels are tailored to local regulatory and healthcare system requirements.
Market Recognition and Index Inclusion
Inclusion in the S&P/ASX 300 (ASX:XKO) and All Ordinaries (ASX:XAO) indexes reflects the company’s role within Australia’s broader listed healthcare segment. These indexes track performance across sectors and highlight companies with increasing market relevance.